a developer of biologic drugs
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.
Ticker / NAME | Correlation To RGEN | 1D Price Change % | ||
---|---|---|---|---|
RGEN | 100% | -6.06% | ||
DHR - RGEN | 67% Closely correlated | -1.89% | ||
TMO - RGEN | 56% Loosely correlated | -1.40% | ||
WAT - RGEN | 56% Loosely correlated | -1.91% | ||
CRL - RGEN | 54% Loosely correlated | -2.89% | ||
BIO - RGEN | 53% Loosely correlated | -0.89% | ||
More |
Ticker / NAME | Correlation To RGEN | 1D Price Change % |
---|---|---|
RGEN | 100% | -6.06% |
RGEN (2 stocks) | 84% Closely correlated | -0.65% |
biological (25 stocks) | 68% Closely correlated | +0.34% |
Medical Specialties (433 stocks) | 58% Loosely correlated | +0.31% |
Medical Specialties (446 stocks) | 58% Loosely correlated | +0.28% |
biotechnology (248 stocks) | 55% Loosely correlated | +5.56% |
More |